Current Evidence Regarding Adjuvant Treatment Option in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Current Evidence Regarding Adjuvant Treatment Option in Renal Cell Carcinoma

Published:2022-10 Issue:4 Volume:34 Page:136-139
ISSN:2241-9136
Container-title:Hellenic Urology
language:en
Short-container-title:

Author:

Fragkoulis Charalampos¹,Stamatakos Panagiotis Velissarios¹,Dellis Athanasios²

Affiliation:

1. Department of Urology, General Hospital of Athens “G. Gennimatas”, Athens, Greece

2. 2nd Department of Surgery, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Abstract

Abstract Surgical treatment consists of the gold standard approach in patients diagnosed with nonmetastatic renal cell carcinoma (RCC). However, a great proportion of such patients will relapse postoperatively and metastatic disease will develop. In the present study, we present a review of the literature about available data regarding adjuvant treatment options in patients with RCC treated surgically.

Publisher

Medknow

Reference24 articles.

1. Oncologic and functional outcomes of radical and partial nephrectomy in pT3a pathologically upstaged renal cell carcinoma:A multi-institutional analysis;Patel;Clin Genitourin Cancer,2020

2. The role of lymph node dissection in the management of renal cell carcinoma:A systematic review and meta-analysis;Bhindi;BJU Int,2018

3. Long-term experience with management of renal cell carcinoma involving the inferior vena cava;Bissada;Urology,2003

4. Survival after complete surgical resection of multiple metastases from renal cell carcinoma;Alt;Cancer,2011

5. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients:A population-based study;Dabestani;World J Urol,2016